| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Howard Hughes Medical Institute [P. B., C. R., B. V.] and Johns Hopkins Oncology Center [B. S. C., K. E. R., S. S., L. Z., B. V., K. W. K.], Johns Hopkins Medical Institutions, Baltimore, Maryland 21231
Serial analysis of gene expression was used to identify transcripts encoding secreted or cell surface proteins that were expressed in benign and malignant tumors of the colorectum. A total of 290,394 tags were analyzed from normal, adenomatous, and cancerous colonic epithelium. Of the 21,343 different transcripts observed, 957 were found to be differentially expressed between normal tissue and adenoma or between normal tissue and cancer. Forty-nine transcripts were elevated
20-fold in adenomas, 40 transcripts were elevated
20-fold in cancers, and 9 transcripts were elevated
20-fold in both. Products of six of these nine transcripts (TGFBI, LYS, RDP, MIC-1, REGA, and DEHL) were predicted to be secreted or to reside on the cell surface, and these were analyzed in more detail. The abnormal expression levels predicted by serial analysis of gene expression were confirmed by quantitative PCR analyses of each of these six genes. Moreover, the cell types responsible for the elevated expression were identified by in situ hybridization and by PCR analyses of epithelial cells immunoaffinity purified from primary tumors. This study extends knowledge of the differences in gene expression that underlie various stages of neoplasia and suggests specific diagnostic approaches that may be useful for the early detection of colorectal neoplasia.
This article has been cited by other articles:
![]() |
L.-M. Chi, C.-W. Lee, K.-P. Chang, S.-P. Hao, H.-M. Lee, Y. Liang, C. Hsueh, C.-J. Yu, I-N. Lee, Y.-J. Chang, et al. Enhanced Interferon Signaling Pathway in Oral Cancer Revealed by Quantitative Proteome Analysis of Microdissected Specimens Using 16O/18O Labeling and Integrated Two-dimensional LC-ESI-MALDI Tandem MS Mol. Cell. Proteomics, July 1, 2009; 8(7): 1453 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yang, J. Lafleur, B. R. Mwaikambo, T. Zhu, C. Gagnon, S. Chemtob, A. Di Polo, and P. Hardy The Role of Lysophosphatidic Acid Receptor (LPA1) in the Oxygen-Induced Retinal Ganglion Cell Degeneration Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1290 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lakhal, N. P. Talbot, A. Crosby, C. Stoepker, A. R. M. Townsend, P. A. Robbins, C. W. Pugh, P. J. Ratcliffe, and D. R. Mole Regulation of growth differentiation factor 15 expression by intracellular iron Blood, February 12, 2009; 113(7): 1555 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Spratlin, N. J. Serkova, and S. G. Eckhardt Clinical Applications of Metabolomics in Oncology: A Review Clin. Cancer Res., January 15, 2009; 15(2): 431 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, Q. Liu, D. Puett, and Y. Xu Computational prediction of human proteins that can be secreted into the bloodstream Bioinformatics, October 15, 2008; 24(20): 2370 - 2375. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, W. M. Ehrhardt, R. B. Halberg, B. J. Aronow, and W. F. Dove Cellular Expression Patterns of Genes Upregulated in Murine and Human Colonic Neoplasms J. Histochem. Cytochem., May 1, 2008; 56(5): 433 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-K. Kim, J. J. Lee, Y. Yang, K.-H. You, and J.-H. Lee Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells Carcinogenesis, April 1, 2008; 29(4): 704 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Chan, O. L. Griffith, I. T. Tai, and S. J.M. Jones Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 543 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ma, Y. Rong, D. R. Radiloff, M. B. Datto, B. Centeno, S. Bao, A. W. M. Cheng, F. Lin, S. Jiang, T. J. Yeatman, et al. Extracellular matrix protein {beta}ig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation Genes & Dev., February 1, 2008; 22(3): 308 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Pangas, X. Li, L. Umans, A. Zwijsen, D. Huylebroeck, C. Gutierrez, D. Wang, J. F. Martin, S. P. Jamin, R. R. Behringer, et al. Conditional Deletion of Smad1 and Smad5 in Somatic Cells of Male and Female Gonads Leads to Metastatic Tumor Development in Mice Mol. Cell. Biol., January 1, 2008; 28(1): 248 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Yochum, S. McWeeney, V. Rajaraman, R. Cleland, S. Peters, and R. H. Goodman Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells PNAS, February 27, 2007; 104(9): 3324 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Hayes, G. Severi, M. C. Southey, E. J.D. Padilla, D. R. English, J. L. Hopper, G. G. Giles, and R. L. Sutherland Macrophage Inhibitory Cytokine-1 H6D Polymorphism, Prostate Cancer Risk, and Survival. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1223 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koopmann, C. N. W. Rosenzweig, Z. Zhang, M. I. Canto, D. A. Brown, M. Hunter, C. Yeo, D. W. Chan, S. N. Breit, and M. Goggins Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9 Clin. Cancer Res., January 15, 2006; 12(2): 442 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roessler, W. Rollinger, S. Palme, M.-L. Hagmann, P. Berndt, A. M. Engel, B. Schneidinger, M. Pfeffer, H. Andres, J. Karl, et al. Identification of Nicotinamide N-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer Clin. Cancer Res., September 15, 2005; 11(18): 6550 - 6557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Johnson, H. F. Frierson, A. Zaika, S. M. Powell, J. Roche, S. Crowe, C. A. Moskaluk, and W. El-Rifai Expression of Tight-Junction Protein Claudin-7 Is an Early Event in Gastric Tumorigenesis Am. J. Pathol., August 1, 2005; 167(2): 577 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Goggins Molecular Markers of Early Pancreatic Cancer J. Clin. Oncol., July 10, 2005; 23(20): 4524 - 4531. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Bauskin, D. A. Brown, S. Junankar, K. K. Rasiah, S. Eggleton, M. Hunter, T. Liu, D. Smith, T. Kuffner, G. J. Pankhurst, et al. The Propeptide Mediates Formation of Stromal Stores of PROMIC-1: Role in Determining Prostate Cancer Outcome Cancer Res., March 15, 2005; 65(6): 2330 - 2336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rohde, M. Daugaard, M. H. Jensen, K. Helin, J. Nylandsted, and M. Jaattela Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms Genes & Dev., March 1, 2005; 19(5): 570 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Jang, H. J. Kang, J. R. Kim, and C. H. Yang Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis Carcinogenesis, October 1, 2004; 25(10): 1853 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lindmark, S. L. Zheng, F. Wiklund, J. Bensen, K. A. Balter, B. Chang, M. Hedelin, J. Clark, P. Stattin, D. A. Meyers, et al. H6D Polymorphism in Macrophage-Inhibitory Cytokine-1 Gene Associated With Prostate Cancer J Natl Cancer Inst, August 18, 2004; 96(16): 1248 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jette, P. W. Peterson, I. T. Sandoval, E. J. Manos, E. Hadley, C. M. Ireland, and D. A. Jones The Tumor Suppressor Adenomatous Polyposis Coli and Caudal Related Homeodomain Protein Regulate Expression of Retinol Dehydrogenase L J. Biol. Chem., August 13, 2004; 279(33): 34397 - 34405. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujiwara, M. Ochiai, T. Ohta, M. Ohki, H. Aburatani, M. Nagao, T. Sugimura, and H. Nakagama Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Carcinogenesis, August 1, 2004; 25(8): 1495 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Park, R. S. Kerbel, G. J. Kelloff, J. C. Barrett, B. A. Chabner, D. R. Parkinson, J. Peck, R. W. Ruddon, C. C. Sigman, and D. J. Slamon Rationale for Biomarkers and Surrogate End Points in Mechanism-Driven Oncology Drug Development Clin. Cancer Res., June 1, 2004; 10(11): 3885 - 3896. [Full Text] [PDF] |
||||
![]() |
G. F. V. Woude, G. J. Kelloff, R. W. Ruddon, H.-M. Koo, C. C. Sigman, J. C. Barrett, R. W. Day, A. P. Dicker, R. S. Kerbel, D. R. Parkinson, et al. Reanalysis of Cancer Drugs: Old Drugs, New Tricks Clin. Cancer Res., June 1, 2004; 10(11): 3897 - 3907. [Full Text] [PDF] |
||||
![]() |
L.-C. Chen, C.-Y. Hao, Y. S. Y. Chiu, P. Wong, J. S. Melnick, M. Brotman, J. Moretto, F. Mendes, A. P. Smith, J. L. Bennington, et al. Alteration of Gene Expression in Normal-Appearing Colon Mucosa of APCmin Mice and Human Cancer Patients Cancer Res., May 15, 2004; 64(10): 3694 - 3700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koopmann, P. Buckhaults, D. A. Brown, M. L. Zahurak, N. Sato, N. Fukushima, L. J. Sokoll, D. W. Chan, C. J. Yeo, R. H. Hruban, et al. Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers Clin. Cancer Res., April 1, 2004; 10(7): 2386 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yang, F. Boucher, A. Tremblay, and J. L. Michaud Regulatory Interaction between Arylhydrocarbon Receptor and SIM1, Two Basic Helix-Loop-Helix PAS Proteins Involved in the Control of Food Intake J. Biol. Chem., March 5, 2004; 279(10): 9306 - 9312. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Lee, Y. Yang, S. J. Lee, K.-Y. Kim, T. H. Koo, S. M. Shin, K. S. Song, Y. H. Lee, Y.-J. Kim, J. J. Lee, et al. Macrophage Inhibitory Cytokine-1 Induces the Invasiveness of Gastric Cancer Cells by Up-Regulating the Urokinase-type Plasminogen Activator System Cancer Res., August 1, 2003; 63(15): 4648 - 4655. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Brown, R. L. Ward, P. Buckhaults, T. Liu, K. E. Romans, N. J. Hawkins, A. R. Bauskin, K. W. Kinzler, B. Vogelstein, and S. N. Breit MIC-1 Serum Level and Genotype: Associations with Progress and Prognosis of Colorectal Carcinoma Clin. Cancer Res., July 1, 2003; 9(7): 2642 - 2650. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jiang, W. Zhang, K. Kondo, J. M. Klco, T. B. St. Martin, M. R. Dufault, S. L. Madden, W. G. Kaelin Jr, and M. Nacht Gene Expression Profiling in a Renal Cell Carcinoma Cell Line: Dissecting VHL and Hypoxia-Dependent Pathways Mol. Cancer Res., April 1, 2003; 1(6): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Welsh, L. M. Sapinoso, S. G. Kern, D. A. Brown, T. Liu, A. R. Bauskin, R. L. Ward, N. J. Hawkins, D. I. Quinn, P. J. Russell, et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum PNAS, March 18, 2003; 100(6): 3410 - 3415. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Williams, R. B. Gaynor, S. Scoggin, U. Verma, T. Gokaslan, C. Simmang, J. Fleming, D. Tavana, E. Frenkel, and C. Becerra Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference Clin. Cancer Res., March 1, 2003; 9(3): 931 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.'e. El-Rifai, M. F. Smith Jr., G. Li, A. Beckler, V. S. Carl, E. Montgomery, S. Knuutila, C. A. Moskaluk, H. F. Frierson Jr., and S. M. Powell Gastric Cancers Overexpress DARPP-32 and a Novel Isoform, t-DARPP Cancer Res., July 15, 2002; 62(14): 4061 - 4064. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |